Cancer stem cells—origins and biomarkers: perspectives for targeted personalized therapies
L Walcher, AK Kistenmacher, H Suo, R Kitte… - Frontiers in …, 2020 - frontiersin.org
The use of biomarkers in diagnosis, therapy and prognosis has gained increasing interest
over the last decades. In particular, the analysis of biomarkers in cancer patients within the …
over the last decades. In particular, the analysis of biomarkers in cancer patients within the …
ABC family transporters
X Liu - Drug transporters in drug disposition, effects and …, 2019 - Springer
The transport of specific molecules across lipid membranes is an essential function of all
living organisms. The processes are usually mediated by specific transporters. One of the …
living organisms. The processes are usually mediated by specific transporters. One of the …
Cancer stem cells: The root of tumor recurrence and metastases
C Peitzsch, A Tyutyunnykova, K Pantel… - Seminars in cancer …, 2017 - Elsevier
Metastatic tumors are the cause of more than 90% of cancer related deaths. Metastasis
formation can be considered as a culmination of the Darwinian evolutionary process within …
formation can be considered as a culmination of the Darwinian evolutionary process within …
The role of ABC transporters in progression and clinical outcome of colorectal cancer
I Hlavata, B Mohelnikova-Duchonova… - …, 2012 - academic.oup.com
Worldwide, colorectal cancer (CRC) is the third most common cancer, with the highest
mortality rates occurring in Central Europe. The use of chemotherapy to treat CRC is limited …
mortality rates occurring in Central Europe. The use of chemotherapy to treat CRC is limited …
Heterogeneity in circulating tumor cells: the relevance of the stem-cell subset
C Agnoletto, F Corrà, L Minotti, F Baldassari, F Crudele… - Cancers, 2019 - mdpi.com
The release of circulating tumor cells (CTCs) into vasculature is an early event in the
metastatic process. The analysis of CTCs in patients has recently received widespread …
metastatic process. The analysis of CTCs in patients has recently received widespread …
[HTML][HTML] Circulating tumour cells: the evolving concept and the inadequacy of their enrichment by EpCAM-based methodology for basic and clinical cancer research
PK Grover, AG Cummins, TJ Price… - Annals of …, 2014 - Elsevier
Increasing evidence suggests that circulating tumour cells (CTCs) are responsible for
metastatic relapse and this has fuelled interest in their detection and quantification. Although …
metastatic relapse and this has fuelled interest in their detection and quantification. Although …
Plasticity of disseminating cancer cells in patients with epithelial malignancies
N Bednarz-Knoll, C Alix-Panabières… - Cancer and Metastasis …, 2012 - Springer
Current models suggest that at a certain but yet undefined time point of tumour development
malignant cells with an aggressive phenotype start to disseminate via the blood stream into …
malignant cells with an aggressive phenotype start to disseminate via the blood stream into …
Colorectal cancer stem cells
AG Vaiopoulos, ID Kostakis, M Koutsilieris… - Stem …, 2012 - academic.oup.com
Colorectal cancer (CRC) is one of the most commonly diagnosed and lethal cancers
worldwide. It is a multistep process that requires the accumulation of genetic/epigenetic …
worldwide. It is a multistep process that requires the accumulation of genetic/epigenetic …
The epithelial-mesenchymal transition and cancer stem cells: functional and mechanistic links
X Liu, D Fan - Current pharmaceutical design, 2015 - ingentaconnect.com
The epithelial-mesenchymal transition (EMT) is a highly conserved cellular process that
transforms epithelial cells into mesenchymal cells; EMT is involved in normal …
transforms epithelial cells into mesenchymal cells; EMT is involved in normal …
[HTML][HTML] CD133: a cancer stem cells marker, is used in colorectal cancers
F Ren, WQ Sheng, X Du - World journal of gastroenterology: WJG, 2013 - ncbi.nlm.nih.gov
Colorectal cancer is one of the most common malignant tumors worldwide. A model of
cancer development involving cancer stem cells has been put forward because it provides a …
cancer development involving cancer stem cells has been put forward because it provides a …